Bremelanotide (PT-141), sold under the brand name Vyleesi, is an FDA-approved injectable medication used to treat low sexual desire (hypoactive sexual desire disorder, HSDD) in premenopausal women. It acts as a melanocortin receptor agonist, enhancing libido and sexual function by acting on the central nervous system rather than the vascular system
Security policy
(Your details are not shared with 3rd parties)
Delivery policy
(Please allow 1-3 business days UK)
Return policy
(No returns)
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent
Write your review
Review sent
Your review cannot be sent
Bremelanotide (PT-141), sold under the brand name Vyleesi, is an FDA-approved injectable medication used to treat low sexual desire (hypoactive sexual desire disorder, HSDD) in premenopausal women. It acts as a melanocortin receptor agonist, enhancing libido and sexual function by acting on the central nervous system rather than the vascular system
check_circle
check_circle
